Related Experiment Video
Updated: Apr 7, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Novel therapeutic targets for steatohepatitis
1Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, MCV Box 980341, Richmond, VA 23298-0341, United States.
Abstract:
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the Western hemisphere and is growing as an indication for liver transplantation. There are currently no approved therapies for NAFLD, especially its aggressive phenotype non-alcoholic steatohepatitis (NASH). However, there has been an explosion of information related to NASH that provides detailed data on the molecular pathogenesis of NASH and its progression to cirrhosis. The current review summarizes the pathophysiological rationale for the selection of specific targets for the treatment of NASH and provides an overview of the current strategies being used for the treatment of NASH and the pathophysiological rationale for the use of these strategies. Specifically, those targets that are being studied in both alcoholic and non-alcoholic steatohepatitis are also mentioned.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Inhibitors of Viral Protein Synthesis
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...

